GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Total Equity

AP Biosciences (ROCO:6945) Total Equity : NT$1,786.65 Mil (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is AP Biosciences Total Equity?

AP Biosciences's total equity for the quarter that ended in Jun. 2024 was NT$1,786.65 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

AP Biosciences Total Equity Historical Data

The historical data trend for AP Biosciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AP Biosciences Total Equity Chart

AP Biosciences Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Total Equity
0.64 558.20 1,098.66 784.11

AP Biosciences Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Equity Get a 7-Day Free Trial - 1,098.66 992.92 784.11 1,786.65

AP Biosciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

AP Biosciences's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=890.756-106.65
=784.11

AP Biosciences's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=1889.711-103.063
=1,786.65

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AP Biosciences Total Equity Related Terms

Thank you for viewing the detailed overview of AP Biosciences's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

AP Biosciences Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AP Biosciences Inc (ROCO:6945) » Definitions » Total Equity
Comparable Companies
ROCO:6461 ROCO:6704 ROCO:4169 ROCO:6926 ROCO:4911 ROCO:4168 ROCO:1777 ROCO:4130 ROCO:4194 ROCO:6733 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 3, Park Street, 17th Floor, Taipei, TWN
Website
https://www.apbioinc.com
AP Biosciences Inc is a clinical-stage bispecific antibody new drug research and development company. It has developed a series of antibody and protein lead drugs through a self-designed technology platform for unmet medical needs, focusing on Specific targets associated with diseases to deliver safe, effective and cost-effective medicines.

AP Biosciences Headlines

No Headlines